MSB 10.4% $1.49 mesoblast limited

Cell Therapy News/Articles, page-3802

  1. Yor
    150 Posts.
    lightbulb Created with Sketch. 70
    thank you for this. If SOC improved placebo it may also have helped patients receiving Rem-L, Mutatis Mutandis. So probably less than 25% (3/12).
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.